Build a strong evidence ecosystem

We support clients at every stage of the evidence generation process

The landscape for evidence generation has evolved in recent times. This is largely driven by rapid and profound changes in the medical product development landscape. Technological advances and healthcare reforms have reshaped the evidence requirements, such that there is a paradigm shift from a narrow focus on efficacy and safety to evidence informing real-world decisions on approval, coverage and clinical use of treatments.

At Clarivate, we offer evidence generation services that suit all sectors and levels of experience of stakeholders. We combine the rigors of conventional systematic literature review methodology with technical and operational proficiencies to engage seamlessly with our stakeholders to provide the best-in-class evidence experience.

Our literature reviews support a variety of requirements from early landscape evidence to HTA submissions, commercial launch and market access activities.

See how we’ve partnered with clients on their evidence generation activities

Download the case studies to see how we have partnered with clients to deliver results and improve outcomes


Type 2 diabetes mellitus
Systematic literature review and network meta-analysis of patient outcomes


Psoriatic arthritis
Updating a complex network meta-analysis to support regulatory submission


Stroke in type 2 diabetes mellitus patients
Systematic literature review of costs in six countries


Systematic lupus erythematosus (SLE)
Targeted literature review in APAC

Click here to contact us for further information

[pardot-form width=”100%” id=”23861″ height=”1425″ title=”T1_ GCSAbacus_SLR_Casestudy_Apr2021″]